 | • レポートコード：20QY06-04109 • 出版社/出版日：QYResearch / 2020年6月1日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、141ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、メロキシカム薬のグローバル市場について種類別（タブレット、カプセル）、用途別（成人性変形性関節症（OA）、成人性関節リウマチ（RA）、小児患者）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・メロキシカム薬市場の概要 ・世界の主要地域別メロキシカム薬市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のメロキシカム薬市場規模2015-2026：種類別（タブレット、カプセル） ・世界のメロキシカム薬市場規模2015-2026：用途別（成人性変形性関節症（OA）、成人性関節リウマチ（RA）、小児患者） ・メロキシカム薬の北米市場規模2015-2020 ・メロキシカム薬のヨーロッパ市場規模2015-2020 ・メロキシカム薬の中国市場規模2015-2020 ・メロキシカム薬の日本市場規模2015-2020 ・メロキシカム薬の東南アジア市場規模2015-2020 ・メロキシカム薬のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Boehringer-Ingelheim、TerSera Therapeutics、Iroko Pharmaceuticals、Apotex、Yung Shin Pharmaceutical、Breckenridge Pharmaceutical、Zydus Pharmaceuticals、Unichem Pharmaceuticals、Strides Pharma、Cipla、Dr. Reddy's Laboratories、Glenmark Pharmaceuticals、Teva、PuraCap Pharmaceutical、TARO、Lupin Pharmaceuticals、Aurobindo Pharma） ・メロキシカム薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・メロキシカム薬の市場動向・機会・課題 ・調査の結論 |
Meloxicam (Mobic) is used to treat pain or inflammation caused by osteoarthritis or rheumatoid arthritis.
Market Analysis and Insights: Global Meloxicam Drug Market
The global Meloxicam Drug market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026.
Global Meloxicam Drug Scope and Market Size
The global Meloxicam Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Meloxicam Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Meloxicam Drug market is segmented into
Tablet
Capsule
Segment by Application, the Meloxicam Drug market is segmented into
Osteoarthritis in adults (OA)
Rheumatoid Arthritis in adults (RA)
Pediatric patients
The Meloxicam Drug market is analysed and market size information is provided by regions (countries). Segment by Application, the Meloxicam Drug market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Meloxicam Drug Market Share Analysis
Meloxicam Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Meloxicam Drug business, the date to enter into the Meloxicam Drug market, Meloxicam Drug product introduction, recent developments, etc.
The major vendors covered:
Boehringer-Ingelheim
TerSera Therapeutics
Iroko Pharmaceuticals
Apotex
Yung Shin Pharmaceutical
Breckenridge Pharmaceutical
Zydus Pharmaceuticals
Unichem Pharmaceuticals
Strides Pharma
Cipla
Dr. Reddy’s Laboratories
Glenmark Pharmaceuticals
Teva
PuraCap Pharmaceutical
TARO
Lupin Pharmaceuticals
Aurobindo Pharma
Table of Contents
1 Meloxicam Drug Market Overview
1.1 Meloxicam Drug Product Scope
1.2 Meloxicam Drug Segment by Type
1.2.1 Global Meloxicam Drug Sales by Type (2020-2026)
1.2.2 Tablet
1.2.3 Capsule
1.3 Meloxicam Drug Segment by Application
1.3.1 Global Meloxicam Drug Sales Comparison by Application (2020-2026)
1.3.2 Osteoarthritis in adults (OA)
1.3.3 Rheumatoid Arthritis in adults (RA)
1.3.4 Pediatric patients
1.4 Meloxicam Drug Market Estimates and Forecasts (2015-2026)
1.4.1 Global Meloxicam Drug Sales Growth Rate (2015-2026)
1.4.2 Global Meloxicam Drug Revenue and Growth Rate (2015-2026)
1.4.3 Global Meloxicam Drug Price Trends (2015-2026)
2 Meloxicam Drug Estimate and Forecast by Region
2.1 Global Meloxicam Drug Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Meloxicam Drug Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Meloxicam Drug Sales Market Share by Region (2015-2020)
2.2.2 Global Meloxicam Drug Revenue Market Share by Region (2015-2020)
2.3 Global Meloxicam Drug Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Meloxicam Drug Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Meloxicam Drug Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Meloxicam Drug Estimates and Projections (2015-2026)
2.4.2 Europe Meloxicam Drug Estimates and Projections (2015-2026)
2.4.3 China Meloxicam Drug Estimates and Projections (2015-2026)
2.4.4 Japan Meloxicam Drug Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Meloxicam Drug Estimates and Projections (2015-2026)
2.4.6 India Meloxicam Drug Estimates and Projections (2015-2026)
3 Global Meloxicam Drug Competition Landscape by Players
3.1 Global Top Meloxicam Drug Players by Sales (2015-2020)
3.2 Global Top Meloxicam Drug Players by Revenue (2015-2020)
3.3 Global Meloxicam Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Meloxicam Drug as of 2019)
3.4 Global Meloxicam Drug Average Price by Company (2015-2020)
3.5 Manufacturers Meloxicam Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Meloxicam Drug Players (Opinion Leaders)
4 Global Meloxicam Drug Market Size by Type
4.1 Global Meloxicam Drug Historic Market Review by Type (2015-2020)
4.1.1 Global Meloxicam Drug Sales Market Share by Type (2015-2020)
4.1.2 Global Meloxicam Drug Revenue Market Share by Type (2015-2020)
4.1.3 Global Meloxicam Drug Price by Type (2014-2020)
4.2 Global Meloxicam Drug Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Meloxicam Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Meloxicam Drug Revenue Forecast by Type (2021-2026)
4.2.3 Global Meloxicam Drug Price Forecast by Type (2021-2026)
5 Global Meloxicam Drug Market Size by Application
5.1 Global Meloxicam Drug Historic Market Review by Application (2015-2020)
5.1.1 Global Meloxicam Drug Sales Market Share by Application (2015-2020)
5.1.2 Global Meloxicam Drug Revenue Market Share by Application (2015-2020)
5.1.3 Global Meloxicam Drug Price by Application (2015-2020)
5.2 Global Meloxicam Drug Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Meloxicam Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Meloxicam Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Meloxicam Drug Price Forecast by Application (2021-2026)
3 North America Meloxicam Drug Market Facts & Figures
3.2 North America Meloxicam Drug Sales Market Share by Company (2015-2020)
3.3 North America Meloxicam Drug Sales Market Share by Type (2015-2020)
3.4 North America Meloxicam Drug Sales Market Share by Application (2015-2020)
4 Europe Meloxicam Drug Market Facts & Figures
4.2 Europe Meloxicam Drug Sales Market Share by Company (2015-2020)
4.3 Europe Meloxicam Drug Sales Market Share by Type (2015-2020)
4.4 Europe Meloxicam Drug Sales Market Share by Application (2015-2020)
5 China Meloxicam Drug Market Facts & Figures
5.2 China Meloxicam Drug Sales Market Share by Company (2015-2020)
5.3 China Meloxicam Drug Sales Market Share by Type (2015-2020)
5.4 China Meloxicam Drug Sales Market Share by Application (2015-2020)
6 Japan Meloxicam Drug Market Facts & Figures
6.2 Japan Meloxicam Drug Sales Market Share by Company (2015-2020)
6.3 Japan Meloxicam Drug Sales Market Share by Type (2015-2020)
6.4 Japan Meloxicam Drug Sales Market Share by Application (2015-2020)
7 Southeast Asia Meloxicam Drug Market Facts & Figures
7.2 Southeast Asia Meloxicam Drug Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Meloxicam Drug Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Meloxicam Drug Sales Market Share by Application (2015-2020)
8 India Meloxicam Drug Market Facts & Figures
8.2 India Meloxicam Drug Sales Market Share by Company (2015-2020)
8.3 India Meloxicam Drug Sales Market Share by Type (2015-2020)
8.4 India Meloxicam Drug Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Meloxicam Drug Business
12.1 Boehringer-Ingelheim
12.1.1 Boehringer-Ingelheim Meloxicam Drug Corporation Information
12.1.2 Boehringer-Ingelheim Meloxicam Drug Business Overview and Total Revenue
12.1.3 Boehringer-Ingelheim Meloxicam Drug Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Boehringer-Ingelheim Meloxicam Drug Products Offered
12.1.5 Boehringer-Ingelheim Recent Development
12.2 TerSera Therapeutics
12.2.1 TerSera Therapeutics Meloxicam Drug Corporation Information
12.2.2 TerSera Therapeutics Meloxicam Drug Business Overview and Total Revenue
12.2.3 TerSera Therapeutics Meloxicam Drug Sales, Revenue and Gross Margin (2015-2020)
12.2.4 TerSera Therapeutics Meloxicam Drug Products Offered
12.2.5 TerSera Therapeutics Recent Development
12.3 Iroko Pharmaceuticals
12.3.1 Iroko Pharmaceuticals Meloxicam Drug Corporation Information
12.3.2 Iroko Pharmaceuticals Meloxicam Drug Business Overview and Total Revenue
12.3.3 Iroko Pharmaceuticals Meloxicam Drug Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Iroko Pharmaceuticals Meloxicam Drug Products Offered
12.3.5 Iroko Pharmaceuticals Recent Development
12.4 Apotex
12.4.1 Apotex Meloxicam Drug Corporation Information
12.4.2 Apotex Meloxicam Drug Business Overview and Total Revenue
12.4.3 Apotex Meloxicam Drug Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Apotex Meloxicam Drug Products Offered
12.4.5 Apotex Recent Development
12.5 Yung Shin Pharmaceutical
12.5.1 Yung Shin Pharmaceutical Meloxicam Drug Corporation Information
12.5.2 Yung Shin Pharmaceutical Meloxicam Drug Business Overview and Total Revenue
12.5.3 Yung Shin Pharmaceutical Meloxicam Drug Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Yung Shin Pharmaceutical Meloxicam Drug Products Offered
12.5.5 Yung Shin Pharmaceutical Recent Development
12.6 Breckenridge Pharmaceutical
12.6.1 Breckenridge Pharmaceutical Meloxicam Drug Corporation Information
12.6.2 Breckenridge Pharmaceutical Meloxicam Drug Business Overview and Total Revenue
12.6.3 Breckenridge Pharmaceutical Meloxicam Drug Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Breckenridge Pharmaceutical Meloxicam Drug Products Offered
12.6.5 Breckenridge Pharmaceutical Recent Development
12.7 Zydus Pharmaceuticals
12.7.1 Zydus Pharmaceuticals Meloxicam Drug Corporation Information
12.7.2 Zydus Pharmaceuticals Meloxicam Drug Business Overview and Total Revenue
12.7.3 Zydus Pharmaceuticals Meloxicam Drug Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Zydus Pharmaceuticals Meloxicam Drug Products Offered
12.7.5 Zydus Pharmaceuticals Recent Development
12.8 Unichem Pharmaceuticals
12.8.1 Unichem Pharmaceuticals Meloxicam Drug Corporation Information
12.8.2 Unichem Pharmaceuticals Meloxicam Drug Business Overview and Total Revenue
12.8.3 Unichem Pharmaceuticals Meloxicam Drug Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Unichem Pharmaceuticals Meloxicam Drug Products Offered
12.8.5 Unichem Pharmaceuticals Recent Development
12.9 Strides Pharma
12.9.1 Strides Pharma Meloxicam Drug Corporation Information
12.9.2 Strides Pharma Meloxicam Drug Business Overview and Total Revenue
12.9.3 Strides Pharma Meloxicam Drug Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Strides Pharma Meloxicam Drug Products Offered
12.9.5 Strides Pharma Recent Development
12.10 Cipla
12.10.1 Cipla Meloxicam Drug Corporation Information
12.10.2 Cipla Meloxicam Drug Business Overview and Total Revenue
12.10.3 Cipla Meloxicam Drug Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Cipla Meloxicam Drug Products Offered
12.10.5 Cipla Recent Development
12.11 Dr. Reddy’s Laboratories
12.11.1 Dr. Reddy’s Laboratories Meloxicam Drug Corporation Information
12.11.2 Dr. Reddy’s Laboratories Meloxicam Drug Business Overview and Total Revenue
12.11.3 Dr. Reddy’s Laboratories Meloxicam Drug Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Dr. Reddy’s Laboratories Meloxicam Drug Products Offered
12.11.5 Dr. Reddy’s Laboratories Recent Development
12.12 Glenmark Pharmaceuticals
12.12.1 Glenmark Pharmaceuticals Meloxicam Drug Corporation Information
12.12.2 Glenmark Pharmaceuticals Meloxicam Drug Business Overview and Total Revenue
12.12.3 Glenmark Pharmaceuticals Meloxicam Drug Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Glenmark Pharmaceuticals Meloxicam Drug Products Offered
12.12.5 Glenmark Pharmaceuticals Recent Development
12.13 Teva
12.13.1 Teva Meloxicam Drug Corporation Information
12.13.2 Teva Meloxicam Drug Business Overview and Total Revenue
12.13.3 Teva Meloxicam Drug Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Teva Meloxicam Drug Products Offered
12.13.5 Teva Recent Development
12.14 PuraCap Pharmaceutical
12.14.1 PuraCap Pharmaceutical Meloxicam Drug Corporation Information
12.14.2 PuraCap Pharmaceutical Meloxicam Drug Business Overview and Total Revenue
12.14.3 PuraCap Pharmaceutical Meloxicam Drug Sales, Revenue and Gross Margin (2015-2020)
12.14.4 PuraCap Pharmaceutical Meloxicam Drug Products Offered
12.14.5 PuraCap Pharmaceutical Recent Development
12.15 TARO
12.15.1 TARO Meloxicam Drug Corporation Information
12.15.2 TARO Meloxicam Drug Business Overview and Total Revenue
12.15.3 TARO Meloxicam Drug Sales, Revenue and Gross Margin (2015-2020)
12.15.4 TARO Meloxicam Drug Products Offered
12.15.5 TARO Recent Development
12.16 Lupin Pharmaceuticals
12.16.1 Lupin Pharmaceuticals Meloxicam Drug Corporation Information
12.16.2 Lupin Pharmaceuticals Meloxicam Drug Business Overview and Total Revenue
12.16.3 Lupin Pharmaceuticals Meloxicam Drug Sales, Revenue and Gross Margin (2015-2020)
12.16.4 Lupin Pharmaceuticals Meloxicam Drug Products Offered
12.16.5 Lupin Pharmaceuticals Recent Development
12.17 Aurobindo Pharma
12.17.1 Aurobindo Pharma Meloxicam Drug Corporation Information
12.17.2 Aurobindo Pharma Meloxicam Drug Business Overview and Total Revenue
12.17.3 Aurobindo Pharma Meloxicam Drug Sales, Revenue and Gross Margin (2015-2020)
12.17.4 Aurobindo Pharma Meloxicam Drug Products Offered
12.17.5 Aurobindo Pharma Recent Development
13 Meloxicam Drug Manufacturing Cost Analysis
13.1 Meloxicam Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Meloxicam Drug
13.4 Meloxicam Drug Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Meloxicam Drug Distributors List
14.3 Meloxicam Drug Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Meloxicam Drug Sales (K MT) Growth Rate by Type (2020-2026)
Table 2. Global Meloxicam Drug Sales (K MT) Comparison by Application (2020-2026)
Table 3. Global Market Meloxicam Drug Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Meloxicam Drug Sales (K MT) by Region (2015-2020)
Table 5. Global Meloxicam Drug Sales Market Share by Region (2015-2020)
Table 6. Global Meloxicam Drug Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Meloxicam Drug Revenue Share by Region (2015-2020)
Table 8. Global Meloxicam Drug Sales (K MT) Forecast by Region (2021-2026)
Table 9. Global Meloxicam Drug Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Meloxicam Drug Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Meloxicam Drug Revenue Share Forecast by Region (2021-2026)
Table 12. Global Meloxicam Drug (K MT) of Key Companies (2015-2020)
Table 13. Global Meloxicam Drug Sales Share by Company (2015-2020)
Table 14. Global Meloxicam Drug Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Meloxicam Drug Revenue Share by Company (2015-2020)
Table 16. Global Meloxicam Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Meloxicam Drug as of 2019)
Table 17. Global Meloxicam Drug Average Price (USD/MT) of Key Company (2015-2020)
Table 18. Manufacturers Meloxicam Drug Manufacturing Sites and Area Served
Table 19. Manufacturers Meloxicam Drug Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Meloxicam Drug Players
Table 22. Global Meloxicam Drug Sales (K MT) by Type (2015-2020)
Table 23. Global Meloxicam Drug Sales Share by Type (2015-2020)
Table 24. Global Meloxicam Drug Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Meloxicam Drug Price (K MT) by Type (2015-2020)
Table 26. Global Meloxicam Drug Sales Share by Type (2021-2026)
Table 27. Global Meloxicam Drug Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Meloxicam Drug Revenue Share by Type (2021-2026)
Table 29. Global Meloxicam Drug Price (K MT) by Type (2021-2026)
Table 30. Global Meloxicam Drug Sales (K MT) by Application (2015-2020)
Table 31. Global Meloxicam Drug Sales Share by Application (2015-2020)
Table 32. Global Meloxicam Drug Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Meloxicam Drug Price (K MT) by Application (2015-2020)
Table 34. Global Meloxicam Drug Sales (K MT) by Application (2021-2026)
Table 35. Global Meloxicam Drug Sales Share by Application (2021-2026)
Table 36. Global Meloxicam Drug Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Meloxicam Drug Revenue Share by Application (2021-2026)
Table 38. Global Meloxicam Drug Price (K MT) by Application (2021-2026)
Table 39. United States Meloxicam Drug Sales (K MT) by Company (2015-2020)
Table 40. United States Meloxicam Drug Sales Market Share by Company (2015-2020)
Table 41. United States Meloxicam Drug Sales (K MT) by Type (2015-2020)
Table 42. United States Meloxicam Drug Sales Market Share by Type (2015-2020)
Table 43. United States Meloxicam Drug Sales (K MT) by Application (2015-2020)
Table 44. United States Meloxicam Drug Sales Market Share by Application (2015-2020)
Table 45. Europe Meloxicam Drug Sales (K MT) by Company (2015-2020)
Table 46. Europe Meloxicam Drug Sales Market Share by Company (2015-2020)
Table 47. Europe Meloxicam Drug Sales (K MT) by Type (2015-2020)
Table 48. Europe Meloxicam Drug Sales Market Share by Type (2015-2020)
Table 49. Europe Meloxicam Drug Sales (K MT) by Application (2015-2020)
Table 50. Europe Meloxicam Drug Sales Market Share by Type (2015-2020)
Table 51. China Meloxicam Drug Sales (K MT) by Company (2015-2020)
Table 52. China Meloxicam Drug Sales Market Share by Company (2015-2020)
Table 53. China Meloxicam Drug Sales (K MT) by Type (2015-2020)
Table 54. China Meloxicam Drug Sales Market Share by Type (2015-2020)
Table 55. China Meloxicam Drug Sales (K MT) by Application (2015-2020)
Table 56. China Meloxicam Drug Sales Market Share by Application (2015-2020)
Table 57. Japan Meloxicam Drug Sales (K MT) by Company (2015-2020)
Table 58. Japan Meloxicam Drug Sales Market Share by Company (2015-2020)
Table 59. Japan Meloxicam Drug Sales (K MT) by Type (2015-2020)
Table 60. Japan Meloxicam Drug Sales Market Share by Type (2015-2020)
Table 61. Japan Meloxicam Drug Sales (K MT) by Application (2015-2020)
Table 62. Japan Meloxicam Drug Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Meloxicam Drug Sales (K MT) by Company (2015-2020)
Table 64. Southeast Asia Meloxicam Drug Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Meloxicam Drug Sales (K MT) by Type (2015-2020)
Table 66. Southeast Asia Meloxicam Drug Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Meloxicam Drug Sales (K MT) by Type (2015-2020)
Table 68. Southeast Asia Meloxicam Drug Sales Market Share by Application (2015-2020)
Table 69. India Meloxicam Drug Sales (K MT) by Company (2015-2020)
Table 70. India Meloxicam Drug Sales Market Share by Company (2015-2020)
Table 71. India Meloxicam Drug Sales (K MT) by Type (2015-2020)
Table 72. India Meloxicam Drug Sales Market Share by Type (2015-2020)
Table 73. India Meloxicam Drug Sales (K MT) by Application (2015-2020)
Table 74. India Meloxicam Drug Sales Market Share by Application (2015-2020)
Table 75. Boehringer-Ingelheim Corporation Information
Table 76. Boehringer-Ingelheim Description and Business Overview
Table 77. Boehringer-Ingelheim Meloxicam Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Boehringer-Ingelheim Meloxicam Drug Product
Table 79. Boehringer-Ingelheim Recent Development
Table 80. TerSera Therapeutics Corporation Information
Table 81. TerSera Therapeutics Description and Business Overview
Table 82. TerSera Therapeutics Meloxicam Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. TerSera Therapeutics Meloxicam Drug Product
Table 84. TerSera Therapeutics Recent Development
Table 85. Iroko Pharmaceuticals Corporation Information
Table 86. Iroko Pharmaceuticals Description and Business Overview
Table 87. Iroko Pharmaceuticals Meloxicam Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Iroko Pharmaceuticals Meloxicam Drug Product
Table 89. Iroko Pharmaceuticals Recent Development
Table 90. Apotex Corporation Information
Table 91. Apotex Description and Business Overview
Table 92. Apotex Meloxicam Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Apotex Meloxicam Drug Product
Table 94. Apotex Recent Development
Table 95. Yung Shin Pharmaceutical Corporation Information
Table 96. Yung Shin Pharmaceutical Description and Business Overview
Table 97. Yung Shin Pharmaceutical Meloxicam Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Yung Shin Pharmaceutical Meloxicam Drug Product
Table 99. Yung Shin Pharmaceutical Recent Development
Table 100. Breckenridge Pharmaceutical Corporation Information
Table 101. Breckenridge Pharmaceutical Description and Business Overview
Table 102. Breckenridge Pharmaceutical Meloxicam Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Breckenridge Pharmaceutical Meloxicam Drug Product
Table 104. Breckenridge Pharmaceutical Recent Development
Table 105. Zydus Pharmaceuticals Corporation Information
Table 106. Zydus Pharmaceuticals Description and Business Overview
Table 107. Zydus Pharmaceuticals Meloxicam Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Zydus Pharmaceuticals Meloxicam Drug Product
Table 109. Zydus Pharmaceuticals Recent Development
Table 110. Unichem Pharmaceuticals Corporation Information
Table 111. Unichem Pharmaceuticals Meloxicam Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Unichem Pharmaceuticals Description and Business Overview
Table 113. Unichem Pharmaceuticals Meloxicam Drug Product
Table 114. Unichem Pharmaceuticals Recent Development
Table 115. Strides Pharma Corporation Information
Table 116. Strides Pharma Meloxicam Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Strides Pharma Description and Business Overview
Table 118. Strides Pharma Meloxicam Drug Product
Table 119. Strides Pharma Recent Development
Table 120. Cipla Corporation Information
Table 121. Cipla Description and Business Overview
Table 122. Cipla Meloxicam Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 123. Cipla Meloxicam Drug Product
Table 124. Cipla Recent Development
Table 125. Dr. Reddy's Laboratories Corporation Information
Table 126. Dr. Reddy's Laboratories Description and Business Overview
Table 127. Dr. Reddy's Laboratories Meloxicam Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 128. Dr. Reddy's Laboratories Meloxicam Drug Product
Table 129. Dr. Reddy's Laboratories Recent Development
Table 130. Glenmark Pharmaceuticals Corporation Information
Table 131. Glenmark Pharmaceuticals Description and Business Overview
Table 132. Glenmark Pharmaceuticals Meloxicam Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 133. Glenmark Pharmaceuticals Meloxicam Drug Product
Table 134. Glenmark Pharmaceuticals Recent Development
Table 135. Teva Corporation Information
Table 136. Teva Description and Business Overview
Table 137. Teva Meloxicam Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 138. Teva Meloxicam Drug Product
Table 139. Teva Recent Development
Table 140. PuraCap Pharmaceutical Corporation Information
Table 141. PuraCap Pharmaceutical Description and Business Overview
Table 142. PuraCap Pharmaceutical Meloxicam Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 143. PuraCap Pharmaceutical Meloxicam Drug Product
Table 144. PuraCap Pharmaceutical Recent Development
Table 145. TARO Corporation Information
Table 146. TARO Description and Business Overview
Table 147. TARO Meloxicam Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 148. TARO Meloxicam Drug Product
Table 149. TARO Recent Development
Table 150. Lupin Pharmaceuticals Corporation Information
Table 151. Lupin Pharmaceuticals Description and Business Overview
Table 152. Lupin Pharmaceuticals Meloxicam Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 153. Lupin Pharmaceuticals Meloxicam Drug Product
Table 154. Lupin Pharmaceuticals Recent Development
Table 155. Aurobindo Pharma Corporation Information
Table 156. Aurobindo Pharma Description and Business Overview
Table 157. Aurobindo Pharma Meloxicam Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 158. Aurobindo Pharma Meloxicam Drug Product
Table 159. Aurobindo Pharma Recent Development
Table 160. Production Base and Market Concentration Rate of Raw Material
Table 161. Key Suppliers of Raw Materials
Table 162. Meloxicam Drug Distributors List
Table 163. Meloxicam Drug Customers List
Table 164. Market Key Trends
Table 165. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 166. Key Challenges
Table 167. Research Programs/Design for This Report
Table 168. Key Data Information from Secondary Sources
Table 169. Key Data Information from Primary Sources
List of Figures
Figure 1. Meloxicam Drug Product Picture
Figure 2. Global Meloxicam Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Meloxicam Drug Market Share by Application in 2020 & 2026
Figure 6. Osteoarthritis in adults (OA) Examples
Figure 7. Rheumatoid Arthritis in adults (RA) Examples
Figure 8. Pediatric patients Examples
Figure 9. Global Meloxicam Drug Sales (K MT) Growth Rate (2015-2026)
Figure 10. Global Meloxicam Drug Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Meloxicam Drug Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 12. Global Meloxicam Drug Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Meloxicam Drug Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Meloxicam Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Meloxicam Drug Sales (K MT) Growth Rate (2015-2026)
Figure 16. Europe Meloxicam Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Meloxicam Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Meloxicam Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Meloxicam Drug Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Meloxicam Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Meloxicam Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Meloxicam Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Meloxicam Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Meloxicam Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Meloxicam Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Meloxicam Drug Players Market Share by Revenue in Meloxicam Drug 2015 & 2019
Figure 27. Meloxicam Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Meloxicam Drug Revenue Share by Type (2015-2020)
Figure 29. Global Meloxicam Drug Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Meloxicam Drug Revenue Share by Application (2015-2020)
Figure 31. Global Meloxicam Drug Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Meloxicam Drug Sales Market Share by Type in 2019
Figure 33. United States Meloxicam Drug Sales Market Share by Type in 2019
Figure 34. Europe Meloxicam Drug Sales Market Share by Company in 2019
Figure 35. Europe Meloxicam Drug Sales Market Share by Type in 2019
Figure 36. Europe Meloxicam Drug Sales Market Share by Application in 2019
Figure 37. China Meloxicam Drug Sales Market Share by Company in 2019
Figure 38. China Meloxicam Drug Sales Market Share by Type in 2019
Figure 39. China Meloxicam Drug Sales Market Share by Application in 2019
Figure 40. Japan Meloxicam Drug Sales Market Share by Company in 2019
Figure 41. Japan Meloxicam Drug Sales Market Share by Type in 2019
Figure 42. Japan Meloxicam Drug Sales Market Share by Application in 2019
Figure 43. Southeast Asia Meloxicam Drug Sales Market Share by Company in 2019
Figure 44. Southeast Asia Meloxicam Drug Sales Market Share by Type in 2019
Figure 45. Southeast Asia Meloxicam Drug Sales Market Share by Application in 2019
Figure 46. India Meloxicam Drug Sales Market Share by Company in 2019
Figure 47. India Meloxicam Drug Sales Market Share by Type in 2019
Figure 48. India Meloxicam Drug Sales Market Share by Application in 2019
Figure 49. Boehringer-Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. TerSera Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Iroko Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Apotex Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Yung Shin Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Breckenridge Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Zydus Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Unichem Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Strides Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Cipla Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Dr. Reddy's Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Glenmark Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Teva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. PuraCap Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. TARO Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Lupin Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. Aurobindo Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 66. Key Raw Materials Price Trend
Figure 67. Manufacturing Cost Structure of Meloxicam Drug
Figure 68. Manufacturing Process Analysis of Meloxicam Drug
Figure 69. Meloxicam Drug Industrial Chain Analysis
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles
Figure 72. Porter's Five Forces Analysis
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
象皮病薬の世界市場レポート2020 Market Analysis and Insights: Global Elephantiasis Drug Market The global Elephantiasis Drug market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Elephantiasis Drug Scope and Market Size The global Elephantias…- アレルギー鼻炎薬の世界市場レポート2020 Market Analysis and Insights: Global Allergy Rhinitis Drug Market The global Allergy Rhinitis Drug market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Allergy Rhinitis Drug Scope and Market Size The global Al…
- 植物薬の世界市場レポート2020 Market Analysis and Insights: Global Botanical Drug Market The global Botanical Drug market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Botanical Drug Scope and Market Size The global Botanical Drug market i…
- フィブリノーゲン欠乏症薬の世界市場レポート2020 Market Analysis and Insights: Global Fibrinogen Deficiency Drug Market The global Fibrinogen Deficiency Drug market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Fibrinogen Deficiency Drug Scope and Market Siz…
- オクスカルバゼピン薬の世界市場レポート2020 Oxcarbazepine is an anticonvulsant medication primarily used in the treatment of epilepsy. It may also be used as add-on therapy for bipolar disorder in people that have failed or are unable to tolerate other treatments. Market Analysis and Insights: Global Oxcarbazepine Drug Market The global Oxcar…